'Steady decline' in C-peptide starts six months before T1D diagnosis

The findings suggest an early window of opportunity for disease-modifying therapy, researchers say

A longitudinal study tracking people as they develop type 1 diabetes shows that C-peptide levels maintain a steady decline starting six months before clinical diagnosis.